Auditory Brainstem Response Improvements in Hyperbillirubinemic Infants
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Hyperbillirubinemia in infants have been associated with neuronal damage including in the auditory system. Some researchers have suggested that the bilirubin-induced auditory neuronal damages may be temporary and reversible. This study was aimed at investigating the auditory neuropathy and reversibility of auditory abnormalities in hyperbillirubinemic infants. Subjects and Methods: The study participants included 41 full term hyperbilirubinemic infants (mean age 39.24 days) with normal birth weight (3,200- 3,700 grams) that admitted in hospital for hyperbillirubinemia and 39 normal infants (mean age 35.54 days) without any hyperbillirubinemia or other hearing loss risk factors for ruling out maturational changes. All infants in hyperbilirubinemic group had serum bilirubin level more than 20 milligram per deciliter and undergone one blood exchange transfusion. Hearing evaluation for each infant was conducted twice: the first one after hyperbilirubinemia treatment and before leaving hospital and the second one three months after the first hearing evaluation. Hearing evaluations included transient evoked otoacoustic emission (TEOAE) screening and auditory brainstem response (ABR) threshold tracing. Results: The TEOAE and ABR results of control group and TEOAE results of the hyperbilirubinemic group did not change significantly from the first to the second evaluation. However, the ABR results of the hyperbilirubinemic group improved significantly from the first to the second assessment (p=0.025). Conclusions: The results suggest that the bilirubin induced auditory neuronal damage can be reversible over time so we suggest that infants with hyperbilirubinemia who fail the first hearing tests should be reevaluated after 3 months of treatment.
Abstract
Background and Objectives: Hyperbillirubinemia in infants have been associated with neuronal damage including in the auditory system. Some researchers have suggested that the bilirubin-induced auditory neuronal damages may be temporary and reversible. This study was aimed at investigating the auditory neuropathy and reversibility of auditory abnormalities in hyperbillirubinemic infants. Subjects and Methods: The study participants included 41 full term hyperbilirubinemic infants (mean age 39.24 days) with normal birth weight (3,200- 3,700 grams) that admitted in hospital for hyperbillirubinemia and 39 normal infants (mean age 35.54 days) without any hyperbillirubinemia or other hearing loss risk factors for ruling out maturational changes. All infants in hyperbilirubinemic group had serum bilirubin level more than 20 milligram per deciliter and undergone one blood exchange transfusion. Hearing evaluation for each infant was conducted twice: the first one after hyperbilirubinemia treatment and before leaving hospital and the second one three months after the first hearing evaluation. Hearing evaluations included transient evoked otoacoustic emission (TEOAE) screening and auditory brainstem response (ABR) threshold tracing. Results: The TEOAE and ABR results of control group and TEOAE results of the hyperbilirubinemic group did not change significantly from the first to the second evaluation. However, the ABR results of the hyperbilirubinemic group improved significantly from the first to the second assessment (p=0.025). Conclusions: The results suggest that the bilirubin induced auditory neuronal damage can be reversible over time so we suggest that infants with hyperbilirubinemia who fail the first hearing tests should be reevaluated after 3 months of treatment.
참고문헌 (18)
- Shapiro SM, "Bilirubin and the auditory system", J Perinatol, 21(Suppl 1), pp.S52~S55 (2001)
- Haustein MD, "Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse", J Physiol, 588(Pt 23), pp.4683~4693 (2010)
- Rance G, "Auditory neuropathy", dys-synchrony and its perceptual consequences, 2005, pp.9, 1~43
- Rance G, "Clinical findings for a group of infants and young children with auditory neuropathy", Ear Hear, 20, pp.238~252 (1999)
- Berlin CI, "Multi-site diagnosis and management of 260 patients with auditory neuropathy", dys-synchrony (auditory neuropathy spectrum disorder), 2010, pp.49, 30~43
- Kuriyama M, "Auditory brainstem response in hyperbilirubinemic rats: Part II", Pediatr Neurol, 7, pp.375~379 (1991)
- Ye HB, "Bilirubin induces auditory neuropathy in neonatal guinea pigs via auditory nerve fiber damage", J Neurosci Res, 90, pp.2201~2213 (2012)
- Akinpelu OV, "Auditory risk of hyperbilirubinemia in term newborns: a systematic review", Int J Pediatr Otorhinolaryngol, 77, pp.898~905 (2013)
- Silva DP, "Analysis of transient otoacoustic emissions and brainstem evoked auditory potentials in neonates with hyperbilirubinemia", Braz J Otorhinolaryngol, 75, pp.381~386 (2009)
- Hung KL, "Auditory brainstem responses in patients with neonatal hyperbilirubinemia and bilirubin encephalopathy", Brain Dev, 11, pp.297~301 (1989)
- Li CY, "Protein kinase A and C signaling induces bilirubin potentiation of GABA", glycinergic synaptic transmission in rat ventral cochlear nucleus neurons, 2010, pp.1348, 30~41
- el Barbary A, "Auditory nerve of the normal and jaundiced rat. I. Spontaneous discharge rate and cochlear nerve histology", Hear Res, 54, pp.75~90 (1991)
- Porter ML, "Hyperbilirubinemia in the term newborn", Am Fam Physician, 65, pp.599~606 (2002)
- Shaia WT, "The jaundiced gunn rat model of auditory neuropathy", dyssynchrony, 2005, pp.115, 2167~2173
- Boo NY, "Risk factors associated with hearing loss in term neonates with hyperbilirubinaemia", J Trop Pediatr, 40, pp.194~197 (1994)
- Simmons JL, "Auditory neuropathy: case study with hyperbilirubinemia", J Am Acad Audiol, 11, pp.337~347 (2000)
- Hankø E, "Recovery after shortterm bilirubin exposure in human NT2-N neurons", Brain Res, 1103, pp.56~64 (2006)
- Karplus M, "The effects of brain bilirubin deposition on auditory brain stem evoked responses in rats", Early Hum Dev, 16, pp.185~194 (1988)